Dokters Lier en Omstreken
ActiveDokters Lier en Omstreken has been active since 1969 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.68M and a net result of €-389k. Equity is shrinking by ~6.8% per year across the filed fiscal years. Its solvency ranks better than 70% of 2324 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
68
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability4▲+4
Solvency100▲+4
Growth32=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €180k at 30 days acceptable
Liquidity ample (current ratio 2.36 against 1.92 in 2024; short-term debt: 16.9% and cash: 3.1% of total assets), and 20.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
79.8%
Return on assets
-11.6%
Age of the figures
9 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year €-389k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
17 d early
2024
34 d early
2023
54 d early
2022
40 d early
2021
38 d early
2020
31 d early
2019
15 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€2.68M▼ 13.7%
2024 · €3.11M
2018: €4.72M
2019: €4.98M
2020: €4.92M
2021: €4.89M
2022: €4.56M
2023: €4.09M
2024: €3.11M
2018 → 2025
Total assets
€3.36M▼ 23.7%
2024 · €4.41M
2018: €5.53M
2019: €5.73M
2020: €5.52M
2021: €5.29M
2022: €4.93M
2023: €4.76M
2024: €4.41M
2018 → 2025
Net result
€-389k▲ 60.1%
2024 · €-974k
2018: €84k
2019: €355k
2020: €47k
2021: €23k
2022: €-279k
2023: €-417k
2024: €-974k
2018 → 2025
Working capital
€774k▼ 28.4%
2024 · €1.08M
2018: €2.81M
2019: €2.63M
2020: €2.58M
2021: €2.52M
2022: €2.33M
2023: €1.93M
2024: €1.08M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€4.89M-€4.56M▼ 6.9%€4.09M▼ 10.2%€3.11M▼ 24.0%€2.68M▼ 13.7%
Operating result€31k-€-276k€-445k▼ 61.5%€-964k▼ 117%€-424k▲ 56.0%
Net result€23k-€-279k€-417k▼ 49.8%€-974k▼ 133%€-389k▲ 60.1%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €424k in 2025 against €964k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.36M
Fixed assets
€2.02M▼ 5.9%
Current assets
€1.34M▼ 40.6%
Equity and liabilities €3.36M
Equity
€2.68M▼ 13.7%
Debt
€679k▼ 47.6%
The debt ratio falls from 29.4% to 20.2%. Equity and debt are lower.
Key figures and ratios
EBITDA
€-207k▲
2024 · €-738k
Cash flow
€-172k▲
2024 · €-748k
Solvency
79.8%▲
2024 · 70.6%
Current ratio
2.36▲
2024 · 1.92
Quick ratio
2.36▲
2024 · 1.92
Debt / equity
0.25▼
2024 · 0.42
ROE
-14.5%▲
2024 · -31.3%
ROA
-11.6%▲
2024 · -22.1%
Interest coverage
-14.90▲
2024 · -43.76
Debt
€679k▼
2024 · €1.30M
Debt ≤ 1 year
€567k▼
2024 · €1.18M
Debt > 1 year
€112k▼
2024 · €120k
Income taxes
€474▼
2024 · €2k
Staff costs
€1.10M▼
2024 · €1.80M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€4.41M€3.36M▼
Fixed assets21/28€2.15M€2.02M▼
Tangible fixed assets22/27€2.15M€2.02M▼
Land and buildings22€1.83M€1.75M▼
Plant, machinery and equipment23€280k€217k▼
Furniture and vehicles24€43k€58k▲
Current assets29/58€2.26M€1.34M▼
Amounts receivable within one year40/41€220k€126k▼
Trade receivables40€220k€126k▼
Current investments50/53€1.73M€957k▼
Cash at bank and in hand54/58€170k€105k▼
Deferred charges and accrued income490/1€139k€153k▲
Equity and liabilities
Total equity and liabilities10/49€4.41M€3.36M▼
Equity10/15€3.11M€2.68M▼
Contributions10/11€1.47M€1.46M▼
Reserves13€3.04M€3.00M▼
Non-distributable reserves130/1€2.00M-
Other1319€2.00M-
Distributable reserves133€1.04M€3.00M▲
Profit (loss) carried forward14€-1.39M€-1.78M▼
Amounts payable17/49€1.30M€679k▼
Amounts payable after more than one year17€120k€112k▼
Financial debts170/4€120k€112k▼
Amounts payable within one year42/48€1.18M€567k▼
Current portion of amounts payable after more than one year42€127k€70k▼
Trade debts44€290k€327k▲
Suppliers440/4€290k€327k▲
Advances received on contracts in progress46€5k-
Taxes, remuneration and social security45€756k€141k▼
Taxes450/3€197k-
Remuneration and social security454/9€559k€141k▼
Other amounts payable47/48-€30k
Income statement
Code20242025
Remuneration, social security and pensions62€1.80M€1.10M▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€226k€217k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€46k
Other operating charges640/8€19k€20k▲
Non-recurring operating charges66A-€2k
Gross operating margin9900€1.08M€962k▼
Operating profit (loss)9901€-964k€-424k▲
Financial income75/76B€8k€49k▲
Recurring financial income75€8k€49k▲
Financial charges65/66B€17k€14k▼
Recurring financial charges65€17k€14k▼
Profit (loss) for the period before taxes9903€-973k€-389k▲
Income taxes67/77€2k€474▼
Profit (loss) for the period9904€-974k€-389k▲
Profit (loss) for the period to be appropriated9905€-974k€-389k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-1.39M€-1.78M▼
Profit (loss) brought forward from the previous period14P€-417k€-1.39M▼
Transfer from equity791/2€8k€32k▲
Profit to be distributed694/7€8k€32k▲
Other beneficiaries697€8k€32k▲
Social balance
Average headcount (FTE)908716.114.6▼
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
04-08
State Gazette act
Legal-form change · Resignations & appointmentsGeneral meeting · Legal-form conversion · Net-asset statement20 facts ▸
State Gazette act
Legal-form change · Resignations & appointments
General meeting · Legal-form conversion · Net-asset statement20 facts ▸
- General meeting, 30 juni 2026
- Legal-form conversion, Besloten vennootschap
- Net-asset statement, 30 april 2026
- Net-asset statement, 30 april 2026
- Net-asset statement, 30 april 2026
- Share issue, gewone aandelen
- Corporate purpose, Aan professionele zorgverleners lokalen en apparatuur, alsook het nodige personeel, ter beschikking stellen om medische en technische prestaties te verrichten.…
- Director resignation, GOOSSENS Filip (bestuurder)
- Director resignation, VERSTAPPEN Jozef (bestuurder)
- Director resignation, VANDEPITTE Kurt (bestuurder)
- Director resignation, ICHAU Karlien (bestuurder)
- Director resignation, DEBEUF Johan (bestuurder)
- +8 further facts in this act
14-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Weakest financial yearnet €-974k
Net result drops to €-974k, the lowest in the series; recovery starts the following year.
07-06
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
21-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
23-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
16-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Highest result since 2018net €355k ▲324%
Operating result €390k, net result €355k, both a record.
13-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
19-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
30-05
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2026
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
04-08-2026
Alexander Olbrechts: Resigned as Director
04-08-2026
DEBEUF Johan: Resigned as Director
04-08-2026
GOOSSENS Filip: Resigned as Director
04-08-2026
Ichau Karlien: Resigned as Director
04-08-2026
Kurt Vandepitte: Resigned as Director
04-08-2026
VERSTAPPEN Jozef: Resigned as Director
30-06-2026
Alexander Olbrechts: Appointed as Non-statutory director
30-06-2026
Kurt Vandepitte: Appointed as Non-statutory director
Location & real-estate footprint
Registered office, Lier · 1 establishment unit since 1969
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Leuvensevest 6-7-8-92500 LierGround area
794 m²
Building footprint
616 m²
Parcel 12021I0009/00G000, Flanders. Linked by address, not a title deed.
1 establishment unit
Leuvensevest 6-7-8-9, 2500 Lier
since 19692.229.058.020
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12021I0009/00G000 | Flanders | 794 m² | 1 · 616 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Connections & network
3 connected companiesNetwork connections
Shared director
→
Shared director
→
Shared director
→
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 99 EUR awarded · 99 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 99 EUR | 99 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Care and welfare
1 serviceDiagnosecentrum Dokters Lier en Omstreken
Similar companies · same sector, comparable size
OFFICE DE CONTROLE MEDICAL
BE 0401.571.981
Charleroi · Eq €2.67M
VANDEVELDE HUISARTSENPRAKTIJK
BE 0437.711.708
Zwevegem · Eq €2.67M
DR. JANS-SNELLINGS
BE 0899.520.095
Heist-op-den-Berg · Eq €2.72M
Maison Médicale Le car d'or
BE 0468.949.864
Mons · Eq €2.64M
Wijkgezondheidscentrum DE VLIER
BE 0866.121.215
Sint-Niklaas · Eq €2.74M
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 2,418 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded25-04-1969
Fiscal year end31-12
Abbreviation NL
Diagnosecentrum D.L.O
Activities, NACEBEL
85120
86210General medical practice
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:03/480.35.98